ABT vs. LEG
ABT (Abbott Laboratories) and LEG (Leggett & Platt, Incorporated) are both stocks. ABT operates in Medical Devices (Healthcare), while LEG operates in Furnishings, Fixtures & Appliances (Consumer Cyclical). Over the past 10 years, ABT returned 11.01%/yr vs -11.64%/yr for LEG. At a 0.25 correlation, their price movements are largely independent.
Performance
ABT vs. LEG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABT achieves a -26.95% return, which is significantly lower than LEG's -8.64% return. Over the past 10 years, ABT has outperformed LEG with an annualized return of 11.01%, while LEG has yielded a comparatively lower -11.64% annualized return.
ABT
- 1D
- -0.63%
- 1M
- 7.33%
- YTD
- -26.95%
- 6M
- -25.03%
- 1Y
- -30.87%
- 3Y*
- -1.86%
- 5Y*
- -1.83%
- 10Y*
- 11.01%
LEG
- 1D
- -0.10%
- 1M
- -0.60%
- YTD
- -8.64%
- 6M
- -8.50%
- 1Y
- 12.07%
- 3Y*
- -29.34%
- 5Y*
- -25.68%
- 10Y*
- -11.64%
ABT vs. LEG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | -26.95% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
LEG Leggett & Platt, Incorporated | -8.64% | 17.02% | -61.93% | -13.45% | -17.78% | -3.76% | -9.05% | 47.13% | -22.25% | 0.58% |
Correlation
The correlation between ABT and LEG is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Nov 6, 1987 | 0.25 |
Fundamentals
ABT:
$158.10B
LEG:
$1.41B
ABT:
$3.59
LEG:
$1.60
ABT:
25.21
LEG:
6.25
ABT:
3.51
LEG:
0.46
ABT:
2.39
LEG:
1.36
ABT:
$45.13B
LEG:
$3.03B
ABT:
$25.45B
LEG:
$717.40M
ABT:
$10.80B
LEG:
$433.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABT vs. LEG — Risk / Return Rank
ABT
LEG
ABT vs. LEG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Leggett & Platt, Incorporated (LEG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABT | LEG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.52 | ||
| Sortino ratioReturn per unit of downside risk | -2.47 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.09 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 0.43 | -1.22 |
| Martin ratioReturn relative to average drawdown | -1.79 | 0.89 | -2.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABT | LEG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.27 | 0.25 | -1.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.08 | -0.61 | +0.52 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | -0.29 | +0.76 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.49 | 0.20 | +0.29 |
Drawdowns
ABT vs. LEG - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum LEG drawdown of -86.41%. Use the drawdown chart below to compare losses from any high point for ABT and LEG.
Loading charts...
Drawdown Indicators
| ABT | LEG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.66% | -86.41% | +40.75% |
Max Drawdown (1Y)Largest decline over 1 year | -38.99% | -28.51% | -10.48% |
Max Drawdown (3Y)Largest decline over 3 years | -39.64% | -77.39% | +37.75% |
Max Drawdown (5Y)Largest decline over 5 years | -39.64% | -85.42% | +45.78% |
Max Drawdown (10Y)Largest decline over 10 years | -39.64% | -86.41% | +46.77% |
Current DrawdownCurrent decline from peak | -33.84% | -78.87% | +45.03% |
Average DrawdownAverage peak-to-trough decline | -10.83% | -19.63% | +8.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.23% | 13.58% | +3.65% |
Volatility
ABT vs. LEG - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 8.41%, while Leggett & Platt, Incorporated (LEG) has a volatility of 11.27%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than LEG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABT | LEG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 11.27% | -2.86% |
Volatility (6M)Calculated over the trailing 6-month period | 19.45% | 30.79% | -11.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.42% | 49.55% | -25.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.04% | 42.40% | -20.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.67% | 39.77% | -16.10% |
Dividends
ABT vs. LEG - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.70%, more than LEG's 2.00% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.70% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
LEG Leggett & Platt, Incorporated | 2.00% | 1.82% | 6.35% | 6.95% | 5.40% | 4.03% | 3.61% | 3.11% | 4.19% | 2.98% | 2.74% | 3.00% |
Financials
ABT vs. LEG - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Leggett & Platt, Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABT and LEG have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LEG has higher volatility (11.27%) compared to ABT (8.41%). In terms of maximum drawdown, ABT dropped -45.66% vs LEG's -86.41%.
LEG currently has the higher Sharpe Ratio (0.25 vs -1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABT and LEG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer